Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W David Strain

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Aging|March 7, 2017
Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL studyW David Strain, Abhijit S Agarwal, Päivi M Paldánius
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 3, 2019
Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care SettingW David Strain, Phil McEwan, Heena Howitt, et al.
Experimental Physiology|December 2, 2008
Human endothelial function and microvascular ageingPhillip E Gates, W David Strain, Angela C Shore
Mededpublish (2016)|December 11, 2023
The impact of COVID-19 on Medical education and Medical Students. How and when can they return to placements?Colin Macdougall, Peter Dangerfield, David Katz, et al.
Clinical Cardiology|September 8, 2023
Real-world evidence that among atrial fibrillation patients warfarin is associated with reduced nonelective admissions compared with those on DOACsDahai Yu, Julian Brown, W David Strain, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 8, 2021
Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 DiabetesW David Strain, Su Down, Pam Brown, et al.
Clinical Medicine (London, England)|February 13, 2024
Clinical academics' experiences of REF2021Angharad P Davies, Robert McKinley, Mark Gabbay, et al.
Scientific Reports|September 19, 2022
Epidemiological model based periodic intervention policies for COVID-19 mitigation in the United KingdomGianmario Rinaldi, Prathyush P Menon, Antonella Ferrara, et al.
Lancet (London, England)|May 28, 2013
Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled studyW David Strain, Valentina Lukashevich, Wolfgang Kothny, et al.
Diabetes|May 28, 2005
Albumin excretion rate and cardiovascular risk: could the association be explained by early microvascular dysfunction?W David Strain, Nish Chaturvedi, Christopher J Bulpitt, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Aging|March 7, 2017
Individualizing treatment targets for elderly patients with type 2 diabetes: factors influencing clinical decision making in the 24-week, randomized INTERVAL studyW David Strain, Abhijit S Agarwal, Päivi M Paldánius
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 3, 2019
Retrospective Database Analysis Evaluating the Clinical Outcomes of Changing Treatment of People with Type 2 Diabetes Mellitus (T2DM) from Other DPP-4 Inhibitor Therapy to Alogliptin in a Primary Care SettingW David Strain, Phil McEwan, Heena Howitt, et al.
Experimental Physiology|December 2, 2008
Human endothelial function and microvascular ageingPhillip E Gates, W David Strain, Angela C Shore
Mededpublish (2016)|December 11, 2023
The impact of COVID-19 on Medical education and Medical Students. How and when can they return to placements?Colin Macdougall, Peter Dangerfield, David Katz, et al.
Clinical Cardiology|September 8, 2023
Real-world evidence that among atrial fibrillation patients warfarin is associated with reduced nonelective admissions compared with those on DOACsDahai Yu, Julian Brown, W David Strain, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 8, 2021
Diabetes and Frailty: An Expert Consensus Statement on the Management of Older Adults with Type 2 DiabetesW David Strain, Su Down, Pam Brown, et al.
Clinical Medicine (London, England)|February 13, 2024
Clinical academics' experiences of REF2021Angharad P Davies, Robert McKinley, Mark Gabbay, et al.
Scientific Reports|September 19, 2022
Epidemiological model based periodic intervention policies for COVID-19 mitigation in the United KingdomGianmario Rinaldi, Prathyush P Menon, Antonella Ferrara, et al.
Lancet (London, England)|May 28, 2013
Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled studyW David Strain, Valentina Lukashevich, Wolfgang Kothny, et al.
Diabetes|May 28, 2005
Albumin excretion rate and cardiovascular risk: could the association be explained by early microvascular dysfunction?W David Strain, Nish Chaturvedi, Christopher J Bulpitt, et al.
Pageof 7